Xu Yuan
Insider CIK 1858214 · FATE Director · AKRO Director · XLO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FATE FATE THERAPEUTICS INC | A Award deriv | 2026-06-12 | 2026-06-15 | 87,900 | — | $0 | 87,900 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 31,000 | — | $0 | 31,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2025-05-29 | 2025-05-30 | 55,000 | — | $0 | 55,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2024-08-06 | 2024-08-07 | 633 | $4.23 | $2.7K | 8,669 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-06-08 | 2024-06-11 | 26,000 | — | $0 | 26,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2024-06-07 | 2024-06-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2023-08-04 | 2023-08-07 | 632 | $3.71 | $2.3K | 9,302 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2023-06-14 | 2023-06-15 | 3,460 | $5.58 | $19.3K | 9,934 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 13,200 | — | $0 | 13,200 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2023-06-06 | 2023-06-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 13,200 | — | $0 | 13,200 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-13 | 11,893 | — | $0 | 11,893 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-13 | 8,650 | — | $0 | 13,394 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2022-01-04 | 2022-01-06 | 26,400 | — | $0 | 26,400 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2021-08-03 | 2021-08-05 | 7,501 | — | $0 | 7,501 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2021-08-03 | 2021-08-05 | 4,744 | — | $0 | 4,744 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-04-22 | 2021-04-26 | 26,000 | — | $0 | 26,000 | SEC↗ |